Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old-Reference-Cited by-同舟云学术

Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old

Published:2006-02 Issue:2 Volume:67 Page:316-320
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Loeb Stacy,Roehl Kimberly A.,Antenor Jo Ann V.,Catalona William J.,Suarez Brian K.,Nadler Robert B.

Publisher

Elsevier BV

Subject

Urology

Reference16 articles.

1. Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study;Antenor;J Urol,2004

2. Low levels of prostate-specific antigen predict long-term risk of prostate cancer;Fang;Urology,2001

3. Screening for prostate cancer in high risk populations;Catalona;J Urol,2002

4. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer;Gann;JAMA,1995

5. Age-specific reference ranges for prostate-specific antigen in black men;Morgan;N Engl J Med,1996

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort;European Urology Oncology;2024-07

2. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States;NEJM Evidence;2024-04-23

3. Adverse Pathological Outcomes in Radical Prostatectomy Specimens in Patients with a Serum Prostate-specific Antigen Level ≤3 ng/mL;The Bulletin of Urooncology;2023-12-04

4. Sexual Quality of Life and Its Contributory Factors in Iranian Couples with Benign Prostatic Hyperplasia- Afflicted Spouses: A Cross-sectional Study;CRESCENT J MED BIOL;2023

5. Prostate cancer screening in African American men: a review of the evidence;JNCI: Journal of the National Cancer Institute;2023-09-15